Tarsus Pharmaceuticals (TARS) Cost of Revenue (2021 - 2026)
Tarsus Pharmaceuticals (TARS) reported Cost of Revenue of $13.89 million for Q3 2026, up 67.2% from $8.31 million a year earlier and up 14.7% from the prior quarter.
Powered by 
Analysis
Tarsus Pharmaceuticals (TARS) Cost of Revenue (2021 - 2026) Analysis & Trends
Over the twelve months ended Sep 30, 2026, Tarsus Pharmaceuticals' Cost of Revenue came in at $46.33 million, up 87.7% year-over-year; for FY2025, it was $30.68 million, up 139.2% from FY2024.
- Cost of Revenue has increased for three consecutive years, with a four-year compound annual growth rate of 96.1% (FY2021 to FY2025).
- By year, Cost of Revenue came in at $12.83 million in FY2024 (+705.1%), $1.59 million in FY2023 (+66.8%), $955,000 in FY2022 (-54.0%) and $2.08 million in FY2021.
- The Q3 2026 figure ranks as the highest quarterly Cost of Revenue in data going back to Q1 2021.
- Year over year, Cost of Revenue has now increased in each of the last nine quarters, with growth averaging 143.5% over the last eight quarters.
- The high point for year-over-year Cost of Revenue in five years was Q3 2024 (growth of 759.9%); the low point was Q1 2022 (a decline of 97.5%).
- Per Business Quant data, the three quarters before Q3 2026 came in at $12.11 million (Q2 2026), $9.4 million (Q1 2026) and $10.93 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 3.93 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 8.10 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 4.29 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 4.89 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 2.95 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 2.79 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 1.57 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 4.03 Bn |
| 10 | Tarsus Pharmaceuticals | 3.64 Bn | 2.07 Bn | 180.68 Mn | 13.89 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 13.89 Mn |
| Jun 30, 2026 | 12.11 Mn |
| Mar 31, 2026 | 9.40 Mn |
| Dec 31, 2025 | 10.93 Mn |
| Sep 30, 2025 | 8.31 Mn |
| Jun 30, 2025 | 6.24 Mn |
| Mar 31, 2025 | 5.21 Mn |
| Dec 31, 2024 | 4.93 Mn |
| Sep 30, 2024 | 3.24 Mn |
| Jun 30, 2024 | 3.00 Mn |
| Mar 31, 2024 | 1.65 Mn |
| Dec 31, 2023 | 1.22 Mn |
| Sep 30, 2023 | 377,000.00 |
| Dec 31, 2022 | 400,000.00 |
| Jun 30, 2022 | 522,000.00 |
| Mar 31, 2022 | 33,000.00 |
| Dec 31, 2021 | -24,000.00 |
| Sep 30, 2021 | 65,000.00 |
| Jun 30, 2021 | 737,000.00 |
| Mar 31, 2021 | 1.30 Mn |
API Access
Tarsus Pharmaceuticals Cost of Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=TARS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cost-of-revenue", "ticker": "TARS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=TARS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();